vimarsana.com

Page 3 - உலகளாவிய உயிர் பாதுகாப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

COVID-19 experts fear Christmas could spark a super-spreading event

COVID-19 experts fear Christmas could spark a super-spreading event MonMonday 21 updated MonMonday 21 COVID-19 experts fear Christmas could cause a spike in community transmission. ( Print text only Cancel As Australians prepare to spend Christmas Day with loved ones or at religious services, experts fear the mass movement of people is a super-spreading event waiting to happen. Key points: Overseas events, such as Thanksgiving in the US, caused a spike in cases due to holiday travel There are similar fears COVID-19 will spread within the community after Christmas gatherings Experts advise limiting guests, avoiding share plates and, if you must shop, go when it s quiet

Sydney s coronavirus cases could hit 3,000, disease expert claims

Sydney reported 30 new cases of coronavirus on Sunday, 28 with confirmed links to northern beaches cluster Infectious disease expert Professor Raina MacIntyre said Sydney needs to go into lockdown if cases rise She warned about the dangers of Christmas and New Year s, predicting cases could hit 3,000 by January 8  Prof MacIntyre said NSW needed to improve its digital contact-tracing and efficiency of testing clinics

COVID-19 vaccines are safe, even with long-term data lacking

COVID-19 vaccines are safe, even with long-term data lacking Vaccines have been developed in record time, but medical experts say there has been no skimping on safety. Listen - 10:16 The first COVID-19 vaccineapproved for emergency use by the FDA isn t just a vaccine created in record time to combat the biggest pandemic in recent history. It s also a technological breakthrough that could change how we produce and deliver vaccines in the future. The new vaccine, developed by biotech giant Pfizer and German startup BioNTech, uses messenger RNA, or mRNA, to stimulate the immune system into protecting against infection from the coronavirus. An extensive clinical trial with over 43,000 participants has shown Pfizer s vaccine to be safe and 95% effective against COVID-19. It heralds the beginning of the end for a pandemic that has killed over 1.6 million people across the world

COVID-19 vaccines are safe, even if long-term data is lacking

COVID-19 vaccines are safe, even with long-term data lacking CNET 12/16/2020 © Sarah Tew/CNET The first COVID-19 vaccineapproved for emergency use by the FDA isn t just a vaccine created in record time to combat the biggest pandemic in recent history. It s also a technological breakthrough that could change how we produce and deliver vaccines in the future. The new vaccine, developed by biotech giant Pfizer and German startup BioNTech, uses messenger RNA, or mRNA, to stimulate the immune system into protecting against infection from the coronavirus. An extensive clinical trial with over 43,000 participants has shown Pfizer s vaccine to be safe and 95% effective against COVID-19. It heralds the beginning of the end for a pandemic that has killed over 1.6 million people across the world

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.